{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:19:40Z","timestamp":1740136780568,"version":"3.37.3"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We designed a study to compare the efficacy of cryoprecipitate-reduced plasma (CRP) and fresh frozen plasma (FFP), at the level of individual sessions, for treating refractory thrombotic microangiopathy (TMA) with therapeutic plasma exchange (TPE).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>Platelet counts (\u00d7 10\u00b3\/\u03bcL) and lactate dehydrogenase (LD; IU\/L) levels were measured before and after each session. We compared the mean-percentage and absolute changes in platelet count and LD after each TPE session.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The data from 33 patients treated for TMA between 2009 and 2018 were collected for this study. Both absolute and percentage increases in the platelet count were statistically significant (P = .003 and P = .011, respectively) when CRP was used. However, when patients were divided into subgroups according to specific diagnosis, no significant differences were found among the groups, except in terms of the absolute platelet count increase in the thrombotic thrombocytopenic purpura group (P &amp;lt;.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The platelet count increase was higher when patients received CRP than when they received FFP. We found that CRP may be a rescue option for patients with refractory TMA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/labmed\/lmab092","type":"journal-article","created":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T11:06:54Z","timestamp":1632049614000},"page":"266-272","source":"Crossref","is-referenced-by-count":1,"title":["Is Cryoprecipitate-Reduced Plasma an Efficacious Replacement Fluid for Therapeutic Plasma Exchange for Patients with Thrombotic Microangiopathy? A Single-Center Retrospective Experience"],"prefix":"10.1093","volume":"53","author":[{"given":"Han Joo","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Jeongseok","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyungsuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Hospital , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hyun","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heung-Bum","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-6340","authenticated-orcid":false,"given":"Yousun","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Kangdong Sacred Heart Hospital , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Hyun","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"8","key":"2023020400292396900_CIT0001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med."},{"issue":"6","key":"2023020400292396900_CIT0002","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med."},{"issue":"3","key":"2023020400292396900_CIT0003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher."},{"issue":"2","key":"2023020400292396900_CIT0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/tme.12205","article-title":"Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology","volume":"25","author":"Howell","year":"2015","journal-title":"Transfus Med."},{"key":"2023020400292396900_CIT0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1526-0968.2000.004005327.x","article-title":"Design of the prospective randomized study for the treatment of patients with thrombotic microangiopathy","volume":"4","author":"R\u00f6thele","year":"2000","journal-title":"Ther Apher."},{"issue":"2","key":"2023020400292396900_CIT0006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1996.d01-1800.x","article-title":"Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group","volume":"94","author":"Rock","year":"1996","journal-title":"Br J Haematol."},{"issue":"6","key":"2023020400292396900_CIT0007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jca.21336","article-title":"Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation","volume":"29","author":"Stefanello","year":"2014","journal-title":"J Clin Apher."},{"issue":"5","key":"2023020400292396900_CIT0008","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V65.5.1232.1232","article-title":"Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura","volume":"65","author":"Moake","year":"1985","journal-title":"Blood."},{"issue":"3","key":"2023020400292396900_CIT0009","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajh.2830340303","article-title":"Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura","volume":"34","author":"Byrnes","year":"1990","journal-title":"Am J Hematol."},{"issue":"2","key":"2023020400292396900_CIT0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.2830420214","article-title":"Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura","volume":"42","author":"Obrador","year":"1993","journal-title":"Am J Hematol."},{"issue":"4","key":"2023020400292396900_CIT0011","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jca.2920100404","article-title":"Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura","volume":"10","author":"Owens","year":"1995","journal-title":"J Clin Apher."},{"issue":"1","key":"2023020400292396900_CIT0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jca.1003","article-title":"Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)","volume":"16","author":"Zeigler","year":"2001","journal-title":"J Clin Apher."},{"issue":"1","key":"2023020400292396900_CIT0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.2005.05418.x","article-title":"Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet","volume":"129","author":"Rock","year":"2005","journal-title":"Br J Haematol."},{"issue":"1","key":"2023020400292396900_CIT0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.transci.2006.05.014","article-title":"Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study","volume":"36","author":"Altuntas","year":"2007","journal-title":"Transfus Apher Sci."},{"key":"2023020400292396900_CIT0015","first-page":"1756109","article-title":"Combination of fresh frozen plasma and cryosupernatant plasma for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single institution experience","volume":"2019","author":"Lin","year":"2019","journal-title":"Biomed Res Int."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/53\/3\/266\/49087960\/lmab092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/53\/3\/266\/49087960\/lmab092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:29:42Z","timestamp":1675470582000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/53\/3\/266\/6430061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,11,17]]},"published-print":{"date-parts":[[2022,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmab092","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"type":"print","value":"0007-5027"},{"type":"electronic","value":"1943-7730"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2021,11,17]]}}}